Trans-fatty acids induce pro-inflammatory responses and endothelial cell dysfunction

British Journal of Nutrition

Volumn 99, Issue 4, 2008, Pages 723-731

  Harvey, Kevin A ^a   Arnold, Tyler ^a   Rasool, Tamkeen ^a   Antalis, Caryl ^a   Miller, Steven J ^b   Siddiqui, Rafat A ^a,b,c  

^a METHODIST RESEARCH INSTITUTE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

Adhesion molecules; Capillary morphogenesis; Chemotaxis; Endothelial cells; Trans fatty acids

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; SPHINGOSINE 1 PHOSPHATE; TRANS FATTY ACID; VITRONECTIN RECEPTOR;

ANGIOGENESIS; AORTA; ARTICLE; CELL DIFFERENTIATION; CELL MEMBRANE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; LEUKOCYTE ADHERENCE; MONOCYTE; NEUTROPHIL; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN SECRETION;

BIOLOGICAL MARKERS; CAPILLARIES; CELL ADHESION; CELL DIVISION; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOTAXIS, LEUKOCYTE; ENDOTHELIAL CELLS; FLOW CYTOMETRY; HUMANS; INTEGRIN ALPHAVBETA3; INTERCELLULAR ADHESION MOLECULE-1; LYSOPHOSPHOLIPIDS; MONOCYTES; NEUTROPHILS; SPHINGOSINE; TRANS FATTY ACIDS;

EID: 40449141675     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507842772     Document Type: Article

References (48)

1. Emken EA (1984) Nutrition and biochemistry of trans and positional fatty acid isomets in hydrogenated oils. Annu Rev Nutr 4, 339-376.
2. Allison D, Denke M, Ditschy J, Emken E, Kris-Etherton P & Nicolosi R (1995) Trans fatty acids and coronary heart disease risk. Report of the expert panel on trans fatty acids and coronary heart disease. Am J Clin Nutr 62, 655S-708S.
3. Craig-Schmidt MC (2005) World-wide consumption of trans fatty acids. In First International Symposium on Trans Fatty Acids and Health, p 4. Copenhagen, Denmark, 11-13 September 2005. http://www/meraadet.dk/gfx/uploads/Summaries%20report-s_eng%20side/ Trans%20fatty%20acids%20_%20symposium.pdf
4. Lichtenstein AH (2000) Dietary trans fatty acid. J Cardiopulm Rehabil 20, 143-146.
5. Kemeny Z, Recseg Y, Henon G, Kovari K & Zwobada F (2001) Deodorization of vegetable oils: Prediction of trans polyunsaturated fatty acid content. J Am Oil Chem Soc 78, 973-979.
6. Willett WC (2006) Trans fatty acids and coronary heart disease - epidemiological data. Atherosclerosis 7, Suppl., 5-8.
7. Kromhout D, Menotti A, Bloemberg B, et al. (1995) Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: The Seven Countries Study. Prev Med 24, 308-315.
8. Ascherio A, Rimm EB, Giovannucci EL, Spiegelman D, Stampfer M & Willett WC (1996) Dietary fat and risk of coronary heart disease in men: Cohort follow up study in the United States. BMJ 313, 84-90.
9. Pietinen P, Ascherio A, Korhonen P, Hartman AM, Willett WC, Albanes D & Virtamo J (1997) Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol 145, 876-887.
10. Hu FB, Stampfer MJ, Manson JE, Rimin E, Colditz GA, Rosner BA, Hennekens CH & Willer WC (1997) Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 337, 1491-1499.
11. Stender S, Dyerberg J, Holmer G, Ovesen L & Sandstrom B (1995). The influence of trans fatty acids on health: A report from the Danish Nutrition Council. Clin Sci (Colch) 88, 375-392.
12. Stampfer MJ, Sacks FM, Salvini S, Willett WC & Hennekens CH (1991) A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 325, 373-381.
13. Ascherio A, Katan MB, Zock PL, Stampfer MJ & Willett WC (1999) Trans fatty acids and coronary heart disease. N Engl J Med 340, 1994-1998.
14. Katan MB (2006) Regulation of trans fats: The gap, the Polder, and McDonald's French fries. Atheroscler Suppl 7, 63-66.
15. Mensink RP, Zock PL, Kester ADM & Katan MB (2003) Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: A meta-analysis of 60 controlled trials. Am J Clin Nutr 77, 1146-1155.
16. Ascherio A (2002) Epidemiologic studies on dietary fats and coronary heart disease. Am J Med 113, Suppl. 9B, 9S-12S.
17. Kinsella JE, Bruckner G, Mai J & Shimp J (1981) Metabolism of trans fatty acids with emphasis on the effects of trans, trans octadecadienoate on lipid composition, essential fatty acid, and prostaglandins; an overview. Am J Clin Nutr 34, 23017-2318.
18. Kummerow FA, Zhou Q, Mahfouz MM, Smiricky MR, Grieshop CM & Schaeffer DJ (2004) Trans fatty acids in hydrogenated fat inhibited the synthesis of the polyunsaturated fatty acids in the phospholipid of arterial cells. Life Sci 74, 2707-2723,
19. Mozaffarian D, Rimm EB, King IB, Lawler RL, McDonald GB & Levy WC (2004) Trans fatty acids and systemic inflammation in heart failure. Am J Clin Nutr 80, 1521-1525.
20. Lopez-Garcia E, Schulze MB, Meigs JB, Manson JE, Rifai N, Stampfer MJ, Willett WC & Hu FB (2005) Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr 135, 562-566.
21. de Roos NM, Bots ML & Katan MB (2001) Replacement of dietary saturated fatty acids by trans fatty acids lowers serum HDL cholesterol and impairs endothelial function in healthy men and women. Arterioscler Thromb Vasc Biol 21, 1233-1237.
22. van Greevenbroek MM, Voorhout WF, Erkelens DW, van Meer C & de Bruin TW (1995) Palmitic acid and linoleic acid metabolism in Caco-2 cells: different triglyceride synthesis and lipoprotein secretion. J Lipid Res 36, 13-24.
23. Polch J, Lees M & Sloane-Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226, 497-509.
24. English D, Martin M, Harvey KA, Akard LP, Allen R, Widlanski TS, Garcia JG & Siddiqui RA (1997) Characterization and purification of neutrophil ecto-phosphatidic acid phosphohydrolase. Biochem J 324, 941-950.
25. de Almeida MC, Silva AC, Barral A & Barral M (2000) A simple method for human peripheral blood monocyte isolation. Mem Inst Oswaldo Cruz 95, 221-223.
26. English D, Kovala AT, Welch Z, Harvey KA, Siddiqui RA, Brindley DN & Garcia JG (1999) Induction of endothelial cell chemotaxis by sphingosine 1-phosphate and stabilization of endothelial monolayer barrier function by lysophosphatidic acid, potential mediators of hematopoietic angiogenesis. J Hematother Stem Cell Res 8, 627-634.
27. Boguslawski G, Grogg JR, Harvey KA & English D (2001) Use of DAPI staining for quantitation of cell chemotaxis. Biotechniques 30 42-44.
28. Harvey K, Welch Z, Kovala AT, Garcia JG & English D (2002) Comparative analysis of in vitro angiogenic activities of endothelial cells of heterogeneous origin. Microvasc Res 63, 316-326.
29. Harvey K, Siddiqui RA, Sliva D, Garcia JG & English D (2002) Serum factors involved in human microvascular endothelial cell morphogenesis. J Lab Clin Med 140, 188-198.
30. Lemaitre RN, King IB, Mozaffarian D, Sotoodehnia N, Rea TD, Kuller LH, Tracy RP & Siscovick DS (2006) Plasma phospholipid trans fatty acids, fatal ischemic heart disease, and sudden cardiac death in older adults: The cardiovascular health study. Circulation 114, 209-215.
31. Lagarde M, Sicard B, Guilchardant M, Felisi O & Dechavanne M (1984) Fatty acid composition in native and cultured human endothelial cells. In Vitro 20, 33-37.
32. Kilsdonk EP, Dorsman AN, van Gent T & van Tol A (1992) Effect of phospholipid fatty acid composition of endothelial cells on cholesterol efflux rates. J Lipid Res 33, 1373-1382.
33. Stachowska E, Dolegowska B, Chlubek D, Wesolowska T, Ciechanowski K, Gutowski P, Szumiłowicz H & Turowski R (2004) Dietary trans fatty acids and composition of human atheromatous plaques. Eur J Nutr 43, 313-318.
34. Sun Q, Ma J, Campos H, Hankinson SE, Manson JE, Stampfer MJ, Rexrode KM, Willett WC & Hu FBA (2007) A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation 115, 1858-1865.
35. Lemaitre RN, King IB, Raghunathan TE, Pearce RM, Weinmann S, Knopp RH, Copass MK, Cobb LA & Siscovick DS (2002) Cell membrane trans-fatty acids and the risk of primary cardiac arrest. Circulation 105 697-701.
36. Bortolotto JW, Reis C, Ferreira A, Costa S, Mottin CC, Souto AA & Guaragan RM (2005) Higher content of trans fatty acids in abdominal visceral fat of morbidly obese individuals undergoing bariatric surgery compared to non-obese-subjects. Obes Surg 15 1265-1270.
37. Vidgren HM, Louheranta AM, Agren JJ, Schwab US & Uusitupa MI (1998) Divergent incorporation of dietary trans fatty acids in different serum lipid fractions. Lipids 33, 955-962.
38. Small DM & Steiner J (1986) The Physical Chemistry of Lipids. From Aldanes to Phospholipids. Handbook of Lipid Research New York: Plenum Press.
39. Niu S-L, Mitchell DC & Litman BJ (2005) Trans fatty acid derived phospholipids show increased membrane cholesterol and reduced receptor activation as compared to their cis analogs. Biochemistry 44, 4458-4465.
40. Brown DA (2006) Lipid rafts, detergent-resistant membranes, and raft targeting signals. Physiology 21, 430-439.
41. Takeya M, Yoshimura T, Leonard EJ & Takahashi K (1993) Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum Pathol 24, 534-539.
42. English D, Welch Z, Kovala AT, Harvey K, Volpert OV, Brindley DN & Garcia JG (2009) Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. FASEB J 14, 2255-2265.
43. Garcia JG, Liu F, Verin AD, Birukova A, Dechert MA, Gerthoffer WT, Bamberg JR & English D (2001) Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest 108, 689-701.
44. Mallat Z & Tedgui A (2000) Apoptosis in the vasculature: Mechanisms and functional importance. Br J Pharmacol 130, 947-962.
45. Zapolska-Downar D, Kosmider A & Naruszewicz M (2005) Trans fatty acids induce apoptosis in human endothelial cells. J Physiol Pharmacol 56, 611-625.
46. Kummerow FA, Zhou Q & Mahfouz MM (1999) Effect of trans fatty acids on calcium influx into human arterial endothelial cells. Am J Clin Nutr 70, 832-838.
47. Mozaffarian D (2006) Trans fatty acids - effects on systemic inflammation and endothelial function. Atheroscler Suppl 7, 29-32.
48. Kaul D (2001) Molecular link between cholesterol, cytokines and atherosclerosis. Mol Cell Biochem 219, 65-71.